Pauline Wimberger - Gynecology

Author Information

Pauline Wimberger is affiliated with the Gynecology and Obstetrics department at Technische Universitat Dresden Medizinische Fakultat Carl Gustav Carus, located in Dresden, Germany. Her research primarily focuses on various aspects of gynecology, including breast cancer, ovarian cancer, and cervical cancer.

Research Contributions

Pauline Wimberger has made significant contributions to the field of gynecology, with numerous studies addressing critical issues in breast cancer, ovarian cancer, and cervical cancer. Notable works include prospective studies on the maintenance therapy for endometrial cancer, the impact of genetic polymorphisms on breast cancer survival, and comprehensive guidelines for the diagnosis, therapy, and follow-up of cervical cancer. Her research often emphasizes the clinical applications and improvements in patient care through innovative treatments and diagnostic techniques.

Aliases

Pauline Wimberger is also known by other names, including P. Wimberger and P Wimberger.

Publication and Citation Metrics

Metric	Value
Paper Count	436
Citation Count	10,979
H-index	50

Publications:

VP2-2022: Prospective double-blind, randomized phase III ENGOT-EN5/GOG-3055/SIENDO study of oral selinexor/placebo as maintenance therapy after first-line chemotherapy for advanced or recurrent endometrial cancer

DOI: 10.1016/j.annonc.2022.02.223

Year: 2022

FNTB Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast Cancer

DOI: 10.3390/cancers14030468

Year: 2022

Abstract P2-13-16: Dual HER2-blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T. Results from a German non-interventional study (NIS) HELENA (NCT01777958)

DOI: 10.1158/1538-7445.sabcs21-p2-13-16

Year: 2022

No long-term effects of antenatal synthetic glucocorticoid exposure on epigenetic regulation of stress-related genes

DOI: 10.1038/s41398-022-01828-x

Year: 2022

Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical Heterogeneity

DOI: 10.3390/cancers14030603

Year: 2022

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.

DOI: 10.1055/a-1671-2158

Year: 2022

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.

DOI: 10.1055/a-1671-2446

Year: 2022

Diagnostic Benefit of the Detection of Mitotic Figures in Endometriotic Lesions

DOI: 10.1055/a-1580-0601

Year: 2022

627 SCOUT-1: prospective non-interventional study in BRCA/HRD tested ovarian cancer patients eligible for first-line platinum-based chemotherapy

DOI: 10.1136/ijgc-2021-esgo.442

Year: 2021

241 Impact of co-medication on survival in patients with ovarian cancer – A analysis of 4 prospective trials of the AGO-OVAR and ENGOT/GCIG collaborators

DOI: 10.1136/ijgc-2021-esgo.366

Year: 2021

What Does Increased Urine Output Indicate?

What are the Symptoms of Adrenal Dysfunction in Women?

What are the Best Practices for Genital Hygiene?

What are Common Menstrual Cycle Irregularities?

What is Plan B?

What are some myths about COCs?

What is High Risk Obstetrics?

What is Seated Forward Bend?

How Can Patients Verify Coverage?

How to Address Menopause Concerns?

Partnered Content Networks

Relevant Topics